Breast cancer is the most prevalent in Nigeria with over 32,000 cases yearly. Half of the women diagnosed with breast cancer ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...

Elevation Oncology discontinues EO-3021 for gastric and gastroesophageal junction cancers after phase 1 trial shows ...

A recent study published in Nature reveals that a Chinese research team has created an artificial intelligence tool capable ...

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

A Chinese research team has developed an AI tool that predicts liver cancer recurrence risk with 82.2 percent accuracy, ...

By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

Zentalis estimates that about half of PROC patients overexpress Cyclin E1 based on its proprietary immunohistochemistry cutoff. As of the January 13, 2025 data cutoff, the safety and tolerability ...